mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.005 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.006 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.006 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.006 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.007 |